HR: Modest Margin Gains And Earnings Outlook Will Guide Future Value

Analysts have increased their price target for Healthcare Realty Trust from $18.90 to $19.30. They cite a modest improvement in projected revenue growth along with a slight reduction in the company’s discount rate.

Analysts have slightly raised their price target for Healthcare Realty Trust from $18.70 to $18.90. They cited modest improvements in projected profit margin as well as a lower anticipated future price-to-earnings ratio.

Healthcare Realty Trust's analyst price target has been revised slightly upward to $18.70 from $18.56 as analysts factor in modest improvements in projected profit margin and discount rate, even though the outlook for revenue growth is marginally lower. What's in the News The company reported impairments of real estate assets totaling $140,877,000 for the second quarter ended June 30, 2025, up from $120,917,000 a year prior (Key Developments).

Analysts have raised their price target for Healthcare Realty Trust from $17.75 to $18.56. They cite incremental improvements in fair value estimates based on modest adjustments to the discount rate and updated profit margin projections.

The modest increase in Healthcare Realty Trust’s analyst price target reflects a slightly improved consensus revenue growth outlook, with fair value rising from $17.38 to $17.75. What's in the News No share repurchases made in Q2 2025; total buyback to date is 3,679,162 shares (1.03%) for $63.04 million.

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget has increased revenue growth from -1.9% to -1.7%.

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget has increased revenue growth from -2.2% to -0.1%, decreased profit margin from 20.0% to 17.2%, increased future PE multiple from 27.4x to 32.1x and increased shares outstanding growth rate from -0.1% to -0.0%.